Harry Finch

Person

Abington, GB

People

Patents Grantslast 30 patents

Information Patent Grant
Heterocyclic compounds for use in the treatment of cancer
- Patent number 12,358,886
- Issue date Jul 15, 2025
- Artios Pharma Limited
- Peter Blencowe
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Isoxazole compounds as inhibitors of heat shock proteins
- Patent number 9,718,793
- Issue date Aug 1, 2017
- Vernalis (R&D) Ltd.
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole compounds as inhibitors of heat shock proteins
- Patent number 8,507,480
- Issue date Aug 13, 2013
- Vernalis (R&D) Limited
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole compounds as inhibitors of heat shock proteins
- Patent number 8,450,310
- Issue date May 28, 2013
- Vernalis (R&D) Limited
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Isoxazole compounds as inhibitors of heat shock proteins
- Patent number 7,705,027
- Issue date Apr 27, 2010
- Vernalis (Cambridge) Limited
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20250230165
- Publication date Jul 17, 2025
- Artios Pharma Limited
- Owen DAVIS
- C07 - ORGANIC CHEMISTRY
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20240425511
- Publication date Dec 26, 2024
- Artios Pharma Limited
- Owen DAVIS
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20230242503
- Publication date Aug 3, 2023
- Artios Pharma Limited
- Peter BLENCOWE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20220298134
- Publication date Sep 22, 2022
- Artios Pharma Limited
- Peter BLENCOWE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER
- Publication number 20220259174
- Publication date Aug 18, 2022
- Artios Pharma Limited
- Peter BLENCOWE
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
- Publication number 20170326152
- Publication date Nov 16, 2017
- VERNALIS (R&D) LTD.
- Martin James Drysdale
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
- Publication number 20130289026
- Publication date Oct 31, 2013
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isoxazole Compounds As Inhibitors Of Heat Shock Proteins
- Publication number 20120252797
- Publication date Oct 4, 2012
- Vernalis (Cambridge) Limited
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Application
AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIU...
- Publication number 20100204224
- Publication date Aug 12, 2010
- VERNALIS R & D LIMITED
- Richard Hamlyn
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Isozazole Compounds As Inhibitors Of Heat Shock Proteins
- Publication number 20100179138
- Publication date Jul 15, 2010
- Vernalis (cambridge) Limited
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTAGONISTS OF SNS SODIUM CHANNELS
- Publication number 20100105651
- Publication date Apr 29, 2010
- Vernalis (R&D) Limited
- Richard Hamlyn
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Isoxazole compounds as inhibitors of heat shock proteins
- Publication number 20060241106
- Publication date Oct 26, 2006
- Martin James Drysdale
- C07 - ORGANIC CHEMISTRY

Harry Finch

Person

Patents Grantslast 30 patents

Heterocyclic compounds for use in the treatment of cancer

Isoxazole compounds as inhibitors of heat shock proteins

Isoxazole compounds as inhibitors of heat shock proteins

Isoxazole compounds as inhibitors of heat shock proteins

Isoxazole compounds as inhibitors of heat shock proteins

Patents Applicationslast 30 patents

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

HETEROCYCLIC COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

DEUTERATED COMPOUNDS FOR USE IN THE TREATMENT OF CANCER

Isoxazole Compounds As Inhibitors Of Heat Shock Proteins

Isoxazole Compounds As Inhibitors Of Heat Shock Proteins

Isoxazole Compounds As Inhibitors Of Heat Shock Proteins

AZACYCLIC COMPOUNDS AS INHIBITORS OF SENSORY NEURONE SPECIFIC SODIU...

Isozazole Compounds As Inhibitors Of Heat Shock Proteins

ANTAGONISTS OF SNS SODIUM CHANNELS

Isoxazole compounds as inhibitors of heat shock proteins